25
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Implementation of effective strategies to prevent Candida auris transmission in a Quaternary Care Center, Riyadh, Saudi Arabia

, , , , , , , , , , , , , , & ORCID Icon show all
Received 09 Apr 2024, Accepted 14 Jun 2024, Published online: 24 Jun 2024

References

  • Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–44. doi: 10.1111/j.1348-0421.2008.00083.x.
  • Rhodes J, Fisher MC. Global epidemiology of emerging Candida auris. Curr Opin Microbiol. 2019;52:84–89. doi: 10.1016/j.mib.2019.05.008.
  • Alfouzan W, Dhar R, Albarrag A, et al. The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Health. 2019;12(4):451–459. doi: 10.1016/j.jiph.2019.03.009.
  • Abdalhamid R, Almaghrabi S, Althawadi S, et al. First report of Candida auris infections from Saudi Arabia. J Infect Public Health. 2018;11(4):598–599. doi: 10.1016/j.jiph.2018.05.010.
  • Kaki R. Risk factors and mortality of the newly emerging Candida auris in a university hospital in Saudi Arabia. Mycology. 2023;14(3):256–263. doi: 10.1080/21501203.2023.2227218.
  • Alashqar MB, Alabdan L, Khan M, et al. A case report of a Candida auris infection in Saudi Arabia. Cureus. 2021;13(5):e15240.
  • Chen J, Tian S, Han X, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20(1):827. doi: 10.1186/s12879-020-05543-0.
  • Morales-López SE, Parra-Giraldo CM, Ceballos-Garzón A, et al. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg Infect Dis. 2017;23(1):162–164. doi: 10.3201/eid2301.161497.
  • Centers for Disease Control and Prevention (CDC). Increasing threat of spread of antimicrobial-resistant fungus in healthcare facilities. Atlanta Georgia: CDC; 2023.
  • Welsh RM, Bentz ML, Shams A, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic healthcare surface. J Clin Microbiol. 2017;55(10):2996–3005. doi: 10.1128/JCM.00921-17.
  • Short B, Brown J, Delaney C, et al. Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. J Hosp Infect. 2019;103(1):92–96. doi: 10.1016/j.jhin.2019.06.006.
  • Hu S, Zhu F, Jiang W, et al. Retrospective analysis of the clinical characteristics of Candida auris infection worldwide from 2009 to 2020. Front Microbiol. 2021;12:658329. doi: 10.3389/fmicb.2021.658329.
  • Elsawy A, Alquthami K, Alkhutani N, et al. The second confirmed case of Candida auris from Saudi Arabia. J Infect Public Health. 2019;12(6):907–908. doi: 10.1016/j.jiph.2019.07.011.
  • Narayanan A, Selvakumar P, Siddharthan R, et al. ClaID: a rapid method of clade-level identification of the multidrug resistant human fungal pathogen Candida auris. Microbiol Spectr. 2022;10(2):e0063422. doi: 10.1128/spectrum.00634-22.
  • Chow NA, de Groot T, Badali H, et al. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019;25(9):1780–1781. doi: 10.3201/eid2509.190686.
  • De Luca DG, Alexander DC, Dingle TC, et al. Four genomic clades of Candida auris identified in Canada, 2012–2019. Med Mycol. 2022;60(1):myab079. doi: 10.1093/mmy/myab079.
  • Garcia-Jeldes HF, Mitchell R, McGeer A, et al. Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018. Antimicrob Resist Infect Control. 2020;9(1):82. doi: 10.1186/s13756-020-00752-3.
  • Amer HA, AlFaraj S, Alboqami K, et al. Characteristics and mitigation measures of Candida auris infection: descriptive analysis from a Quaternary Care Hospital in Saudi Arabia, 2021–2022. J Epidemiol Glob Health. 2023;13(4):825–830. doi: 10.1007/s44197-023-00154-9.
  • General Directorate of Infection Prevention & Control of Healthcare Facilities. (GDIPC) Candida auris screening guidance ver. 1.0. August 2023 and Guidance for Candida auris Infection Prevention and control measures version 2.0; 2023 [accessed on 2023 Nov 30]. Available online: https://gdipc.sa/Candida%20Auris%20Prevention%20Strategies%20(CAPS).html.
  • Rossow J, Ostrowsky B, Adams E, et al. Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator Units, New York, 2016–2018. Clin Infect Dis. 2021;72(11):e753–e760. doi: 10.1093/cid/ciaa1462.
  • Ahmad S, Asadzadeh M. Strategies to prevent transmission of Candida auris in healthcare settings. Curr Fungal Infect Rep. 2023;17(1):36–48. doi: 10.1007/s12281-023-00451-7.
  • Ahmad S, Khan Z, Al-Sweih N, et al. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Mycoses. 2020;63(1):104–112. doi: 10.1111/myc.13022.
  • Centers for Disease Control and Prevention. Infection prevention and control for Candida auris; 2023 [accessed on 2023 Nov 28]. Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html.
  • Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1):35–29. doi: 10.1186/s13756-016-0132-5.
  • Alshamrani MM, El-Saed A, Mohammed A, et al. Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia. Infect Control Hosp Epidemiol. 2021;42(2):149–155. doi: 10.1017/ice.2020.414.
  • Moore G, Schelenz S, Borman AM, et al. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect. 2017;97(4):371–375. doi: 10.1016/j.jhin.2017.08.019.
  • Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31(1):e00029-17. doi: 10.1128/CMR.00029-17.
  • Public Health England. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. UK: Public Health England; 2017.
  • Shackleton J, Schelenz S, Rochon M, et al. The impact of environmental decontamination in a Candida auris outbreak. J Hosp Infect. 2016;94(1):S24–S134. doi: 10.1016/S0195-6701(16)30516-3.
  • Briano F, Magnasco L, Sepulcri C, et al. Candida auris candidemia in critically ill, colonized patients: cumulative incidence and risk factors. Infect Dis Ther. 2022;11(3):1149–1160. doi: 10.1007/s40121-022-00625-9.
  • Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility and infection control measures to combat the spreading of infections in healthcare facilities. Microorganisms. 2021;9(4):807. doi: 10.3390/microorganisms9040807.
  • Lone SA, Ahmad A. Candida auris-the growing menace to global health. Mycoses. 2019;62(8):620–637. doi: 10.1111/myc.12904.
  • Sarma S, Kumar N, Sharma S, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31(1):90–91. doi: 10.4103/0255-0857.108746.
  • Bandara HMHN, Samaranayake LP. Emerging strategies for environmental decontamination of nosocomial fungal pathogen candida auris. J Med Microbiol. 2022;71(6):001548. doi: 10.1099/jmm.0.001548.
  • Cadnum JL, Shaikh AA, Piedrahita CT, et al. Effectiveness of disinfectants against Candida auris and other Candida species. Infect Control Hosp Epidemiol. 2017;38(10):1240–1243. doi: 10.1017/ice.2017.162.
  • Adams E, Quinn M, Tsay S, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis. 2018;24(10):1816–1824. doi: 10.3201/eid2410.180649.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.